Timothy E. Wilens, MD

Center for the Study of Drugs, Alcohol, Smoking and Health, University of Michigan, Ann Arbor, Michigan; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Harvard University, Boston, Massachusetts

  • 27Articles
  • 134.9KReads
  • 1998–2025Active
  • 83Collaborators
  • 1KCitations

About

Timothy E. Wilens, MD, is affiliated with the Center for the Study of Drugs, Alcohol, Smoking and Health at the University of Michigan, the Department of Psychiatry at Massachusetts General Hospital, and Harvard Medical School. His work, published from 1998 to 2025, focuses on neurodevelopmental disorders, addiction, child and adolescent psychiatry, psychiatry, and bipolar disorder. He has collaborated frequently with Joseph Biederman, Stephen V. Faraone, MaryKate Martelon, Thomas J. Spencer, and Janet Wozniak.

Publications

JCP
Nonmedical Use and Substance Use Disorder Symptoms in US Adults Co-Prescribed Opioids and Benzodiazepines
Brief Report

Nonmedical Use and Substance Use Disorder Symptoms in US Adults Co-Prescribed Opioids and Benzodiazepines

September 8, 2025

While most adults with co-use reported no nonmedical use (NMU), they demonstrated increased odds of NMU and substance use disorder symptoms relative to those prescribed opioids only, benzodiazepines only,...
, , , et al
JCP
In Memoriam: Joseph Biederman, MD
In Memoriam

In Memoriam: Joseph Biederman, MD

February 22, 2023

Colleagues and friends remember Joseph Biederman and reflect on his legacy as the father of pediatric psychopharmacology.
, , , et al
JCP
ADHD Pharmacotherapy and SUD Treatment Retention
Original Research

ADHD Pharmacotherapy and SUD Treatment Retention

February 23, 2021

How does comorbid attention-deficit/hyperactivity disorder (ADHD) affect individuals with substance use disorder (SUD)? Is treatment for ADHD associated with retention in outpatient SUD therapy?
, ,
JCP
Original Research

Stimulant Misuse Motives in Adolescents and Young Adults

November 3, 2020

Prescription stimulant misuse (PSM) is common in adolescents and young adults. Do motives for PSM differ by age in these individuals? This study examined PSM motives across age decades...
, , , et al
JCP
Original Research

Norms for Time-Sensitive Measures of Function in ADHD

December 10, 2019

Children with ADHD often have functional impairments in the early morning and late afternoon and evening. This study sought to establish norms on 2 rating scales to help clinicians...
, , , et al
JCP
Original Research

Risk for Overdose in Youth With SUD

April 24, 2018

Given the high rates of overdose in young people, understanding the risk factors for it in youth with substance use disorders is important. This medical record review of 200...
, , , et al
JCP
Original Research

Sources of Prescription Medication Misuse

March 20, 2018

For preventing prescription drug misuse in young adults, it's important to know the source from which they obtained the drugs. This study used data from a large nationally representative...
, , , et al
JCP
Article

Substance Use Among Youth With Bipolar Disorder

October 26, 2016

Bipolar disorder is often comorbid with other diagnoses including conduct disorder and ADHD. Are youth with bipolar disorder also at risk for initiating smoking and substance use? This study...
, , , et al
PCC
Rounds in the General Hospital

Using Stimulants for Attention-Deficit/Hyperactivity Disorder: Clinical Approaches and Challenges

March 28, 2013

Have you been reluctant to prescribe stimulants for patients with attention-deficit/hyperactivity disorder (ADHD) and comorbid autism, bipolar disorder, or seizures for fear of exacerbating the underlying disorder? In this...
, ,
JCP
Original Research

Randomized Controlled Study of the Histamine H3 Inverse Agonist MK-0249 in Adult Attention-Deficit/Hyperactivity Disorder

July 15, 2012

, , , et al
JCP
Article

Psychosocial Functioning, Familiality, and Psychiatric Comorbidity in Bipolar Youth With and Without Psychotic Features

March 15, 2011

, , , et al
JCP
Original Research

A Controlled Trial of the Methylphenidate Transdermal System on Before-School Functioning in Children With Attention-Deficit/Hyperactivity Disorder

May 15, 2010

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe